Stock Market LIVE Updates: Sensex down 50 pts, Nifty at 25200; SBI, Tech Mahindra, Angel One most active

Emcure has entered into an exclusive distribution and promotion agreement with Sanofi India for Sanofi’s oral anti-diabetic (OAD) drugs, including Amaryl and Cetapin, in India. The agreement is effective immediately.

Emcure Pharmaceuticals was quoting at Rs 1,364.80, up Rs 0.95, or 0.07 percent.

It has touched an intraday high of Rs 1,395.00 and an intraday low of Rs 1,361.50.

It was trading with volumes of 5,856 shares, compared to its five day average of 9,643 shares, a decrease of -39.27 percent.

In the previous trading session, the share closed up 0.22 percent or Rs 2.95 at Rs 1,363.85.

The share touched a 52-week high of Rs 1,577.50 and a 52-week low of Rs 890.00 on 18 September, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 13.48 percent below its 52-week high and 53.35 percent above its 52-week low.

Market capitalisation stands at Rs 25,864.10 crore.